应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BRNS BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON
盘前交易 05-10 05:39:57 EDT
2.35
+0.08
+3.52%
最高
2.40
最低
2.23
成交量
1.02万
今开
2.40
昨收
2.27
日振幅
7.53%
总市值
9,146万
流通市值
4,317万
总股本
3,892万
成交额
2.35万
换手率
0.06%
流通股本
1,837万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Barinthus Biotherapeutics Plc2023财年实现净利润-73.63百万美元,同比减少1478.84%
自选股智能写手 · 03-22
Barinthus Biotherapeutics Plc2023财年实现净利润-73.63百万美元,同比减少1478.84%
加载更多
公司概况
公司名称:
BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON
所属市场:
NASDAQ
上市日期:
--
主营业务:
Barinthus Biotherapeutics plc于2016年1月根据英格兰和威尔士的法律注册成立。他们是一家临床阶段的生物制药公司,致力于发现和开发用于治疗和预防传染病和癌症的新型免疫疗法和疫苗。该公司拥有广泛的临床和临床前阶段治疗和预防项目。该公司目前的治疗方案包括用于治疗慢性乙型肝炎感染的VTP-300,用于治疗人乳头状瘤病毒感染的VTP-200,用于治疗前列腺癌的VTP-850,用于治疗非小细胞肺癌的VTP-600,用于治疗乳糜泻的VTP-1000,以及用于治疗HPV相关癌症的VTP-1100。后两个程序旨在利用SNAPvaxTM平台。该公司目前的预防项目包括用于预防带状疱疹或带状疱疹的VTP-400,以及用于预防中东呼吸综合征或MERS的VTP-500。
发行价格:
--
{"stockData":{"symbol":"BRNS","market":"US","secType":"STK","nameCN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","latestPrice":2.35,"timestamp":1715284800000,"preClose":2.27,"halted":0,"volume":10228,"delay":0,"floatShares":18372170,"shares":38921212,"eps":-1.91075,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.08,"latestTime":"05-10 05:39:57 EDT","open":2.3997,"high":2.3997,"low":2.2288,"amount":23499.065244,"amplitude":0.075286,"askPrice":3.6,"askSize":108,"bidPrice":0.942,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.91075,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715347800000},"adr":0,"listingDate":1619755200000,"adjPreClose":2.34,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"18:41 EDT","volume":1,"amount":2.2,"timestamp":1715294509915},"volumeRatio":2.194661327108014},"requestUrl":"/m/hq/s/BRNS","defaultTab":"news","newsList":[{"id":"2421026976","title":"Barinthus Biotherapeutics Plc2023财年实现净利润-73.63百万美元,同比减少1478.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421026976","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421026976?lang=zh_cn&edition=full","pubTime":"2024-03-22 00:15","pubTimestamp":1711037755,"startTime":"0","endTime":"0","summary":"12月31日,Barinthus Biotherapeutics Plc公布财报,公告显示公司2023财年净利润为-73.63百万美元,同比减少1478.84%;其中营业收入为805108.61美元,同比减少98.20%,每股基本收益为-1.92美元。从资产负债表来看,Barinthus Biotherapeutics Plc总负债27.51百万美元,其中短期债务1.79百万美元,资产负债比为0.08,流动比率为0.13。机构评级:截至2023年12月31日,当前有4家机构对Barinthus Biotherapeutics Plc目标价做出预测,其中目标均价为8.00美元,其中最低目标价为3.00美元,最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032200155787a2b9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032200155787a2b9ba&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.barinthusbio.com","stockEarnings":[{"period":"1week","weight":0.0956},{"period":"1month","weight":-0.2857},{"period":"3month","weight":-0.082},{"period":"6month","weight":-0.2219},{"period":"1year","weight":0.0173},{"period":"ytd","weight":-0.3631}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Barinthus Biotherapeutics plc于2016年1月根据英格兰和威尔士的法律注册成立。他们是一家临床阶段的生物制药公司,致力于发现和开发用于治疗和预防传染病和癌症的新型免疫疗法和疫苗。该公司拥有广泛的临床和临床前阶段治疗和预防项目。该公司目前的治疗方案包括用于治疗慢性乙型肝炎感染的VTP-300,用于治疗人乳头状瘤病毒感染的VTP-200,用于治疗前列腺癌的VTP-850,用于治疗非小细胞肺癌的VTP-600,用于治疗乳糜泻的VTP-1000,以及用于治疗HPV相关癌症的VTP-1100。后两个程序旨在利用SNAPvaxTM平台。该公司目前的预防项目包括用于预防带状疱疹或带状疱疹的VTP-400,以及用于预防中东呼吸综合征或MERS的VTP-500。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.073835},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.075362},{"month":3,"riseRate":0,"avgChangeRate":-0.204075},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.024392},{"month":5,"riseRate":0.75,"avgChangeRate":0.014223},{"month":6,"riseRate":0.666667,"avgChangeRate":0.003102},{"month":7,"riseRate":0.666667,"avgChangeRate":0.024698},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.07204},{"month":9,"riseRate":0.666667,"avgChangeRate":0.120188},{"month":10,"riseRate":0.333333,"avgChangeRate":0.033865},{"month":11,"riseRate":0,"avgChangeRate":-0.208697},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083596}],"exchange":"NASDAQ","name":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON","nameEN":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON,BRNS,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票老虎国际,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票行情,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股价,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股市,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票价格,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票交易,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票购买,BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BARINTHUS BIOTHERAPEUTICS PLC ADR EACH REPR 1 ORD SH SPON(BRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}